WO2004089328A1 - Composition for skin whitening containing machilin-a - Google Patents

Composition for skin whitening containing machilin-a Download PDF

Info

Publication number
WO2004089328A1
WO2004089328A1 PCT/KR2003/000738 KR0300738W WO2004089328A1 WO 2004089328 A1 WO2004089328 A1 WO 2004089328A1 KR 0300738 W KR0300738 W KR 0300738W WO 2004089328 A1 WO2004089328 A1 WO 2004089328A1
Authority
WO
WIPO (PCT)
Prior art keywords
machilin
composition
skin whitening
skin
melanin
Prior art date
Application number
PCT/KR2003/000738
Other languages
French (fr)
Inventor
Won-Chan Kim
Ho-Jeong Kim
Cheong-Taek Kim
Mu-Hyun Jin
Sang-Jin Kang
Seung-Ho Lee
Hyeun-Wook Chang
Jong-Keun Son
Original Assignee
Lg Household & Healthcare Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lg Household & Healthcare Co., Ltd. filed Critical Lg Household & Healthcare Co., Ltd.
Priority to PCT/KR2003/000738 priority Critical patent/WO2004089328A1/en
Priority to AU2003225373A priority patent/AU2003225373A1/en
Publication of WO2004089328A1 publication Critical patent/WO2004089328A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin

Definitions

  • composition for skin whitening and more particularly to composition for skin whitening that has excellent stability with giving no side effects on skin, and have a superior effect to inhibit pigmentation on skin by restraining melanin from being generated.
  • the tone of skin darkens, and chloasma and freckles can be generated. Accordingly, when the melanin synthesis inside skin is inhibited, the skin whitening is possible, plus hyperpigmentation such as chloasma, freckles, etc. due to ultraviolet rays or hormonic and genetic factors can be improved. Conventionally, the skin whitening is tried by mixing material having inhibition function against tyrosinase such as hydroquinone, ascorbic acid, kojic acid, or glutathione with cosmetic such as essence or ointment for external use.
  • tyrosinase such as hydroquinone, ascorbic acid, kojic acid, or glutathione
  • hydroqumone shows a prescribed effect of whitening
  • the mixture amount of the same should be restricted to the minimum since the same seriously irritates skin.
  • cosmetic mixed with the same has problems of discoloration and change of scent.
  • kojic acid the same is restricted to be used since the same is unstable.
  • thiol compound such as glutathione or cysteine has a peculiar bad smell and low absorptiveness to skin.
  • the present invention is designed to solve the problems of the prior art, and an object of the present invention is to provide composition for skin whitening that has excellent stability with giving no side effects on skin, and has a superior effect to inhibit pigmentation on skin by restraining melanin from being generated.
  • composition for skin whitening containing machilin-A expressed by the following Chemical Formula 1 as an effective component.
  • the content of the machilin-A is preferably 0.000001 to 10 weight% on the basis of total weight of the composition, more particularly 0.0001 to 10 weight% on the basis of total weight of the composition.
  • the machilin-A is extracted from Areca catechu by means of at least one solvent selected from the group consisting of low alcohol having 1 to 4 carbon atoms, ethyl acetate, acetone, ether, benzene, chloroform, hexane, cyclohexane and petroleum ether.
  • the composition for skin whitening may have one form selected from the group consisting of skin, lotion, cream, foundation, essence, gel, pack, foam cleansing, soup and ointment for external use.
  • composition for skin whitening according to the present invention will be described in detail.
  • composition for skin whitening contains machilin-A (machilin-A; CAS No. 110269-50-6 5,5'[(2R,3S)-dimethyl-l,4- butanediyl]bis-l, 3-bezodioxole), which is expressed by the following chemical formula 1, as an effective component for skin whitening.
  • machilin-A machilin-A; CAS No. 110269-50-6 5,5'[(2R,3S)-dimethyl-l,4- butanediyl]bis-l, 3-bezodioxole
  • machilin-A is a machilin derivative different from nor- dihydroguaiaretic acid, and may be used as an antioxidant (Chem. Pharm. (1990), 21(4), 270-3).
  • machilin-A is known as an antioxidant
  • the inventors have found that machilin-A show very strong inhibitory effect on formation of melanin and show excellent skin whitening effect as a result from the experiment on B16 mouse melanoma cell which can screen even the material which restrains induction of melanin synthesis itself. Therefore, if machilin-A is added and mixed into the composition for skin whitening such as skin lotion, cream, foundation, essence, gel, pack, foam cleansing, soap and ointment for external use according to the present invention, the high-potency of skin whitening without any special side effect can be obtained.
  • Machilin-A an effective whitening component of the composition for skin whitening according to the present invention, is an organic compound having 20 carbon atoms, and may be obtained from essential oil of a microbe, a plant or an animal.
  • machilin-A may be extracted from peel or root of Area catechu, but not limitedly. An extraction method of machilin-A from Areca catechu will be explained below as an example.
  • the pulverized peel or root is heat-extracted at 50 to 100°C for 1 to 5 hours in an extractor having a spill cooler by means of a coolant such as low alcohol having 1 to 4 carbon atoms, ethyl acetate, acetone, ether, benzene, chloroform, hexane, cyclohexane or petroleum ether.
  • a coolant such as low alcohol having 1 to 4 carbon atoms, ethyl acetate, acetone, ether, benzene, chloroform, hexane, cyclohexane or petroleum ether.
  • the extract is filtered by a filter cloth, and the residue is then extracted once more in the same way and added to the extract liquid, and then vacuum-concentrated, and freeze-dried or spray-dried to obtain a dried extract.
  • the dried extract is suspended in water, adding ethyl acetate of the same amount thereto, thereby obtaining ethyl acetate fraction by
  • fraction is then purified by HPLC (High Performance Liquid Chromatography) or column chromatography filled with silica gel or activated alumina.
  • Machilin-A obtained by the above mentioned method can be added into various skin whitening compositions such as ointment for external use or cosmetic.
  • the content of machilin-A contained in the skin whitening composition of the present invention is preferably 0.000001 to 10 weight% based on the total weight of the composition in consideration of whitening effect and economic efficiency, more preferably 0.0001 to 10 weight%.
  • 105mg of machilin-A was obtained using substantially the same way as the extraction example 1, except that 500ml of 100% ethanol was used instead of 500ml of 100% ethyl acetate.
  • 208mg of machilin-A was obtained using substantially the same way as the extraction example 1, except that 500ml of 100% chloroform was used instead of 500ml of 100% ethyl acetate.
  • a peel of Areca catechu was purchased in the market and then pulverized, and then lOOg of the pulverized peel was put into 500ml of 100% capric/caprilic triester and then boiled in a spill extractor having a cooling condenser for 3 hours for the purpose of extraction. Subsequently, the extract was filtered by a 300-mesh filter cloth, and then filtered by Whatman No.2 filter paper at a room temperature to remove insoluble materials, and then purified by HPLC to obtain 150mg of machilin-A.
  • 208mg of machilin-A was obtained using substantially the same way as the extraction example 1, except that a pulverized root was put instead of the pulverized peel of Areca catechu and 500ml of n-hexane was used instead of 500ml of 100% ethyl acetate.
  • 208mg of machilin-A was obtained using substantially the same way as the extraction example 1, except that 500ml of n-hexane was used instead of 500ml of 100% ethyl acetate.
  • the cultured cells were treated with trypsin, and separated from the culture plate, and then centrifuged to extract melanin.
  • lml of sodium hydroxide solution (IN of concentration) was added to each of above obtained extracts and the mixtures were boiled for 10 minutes for melanin to melt.
  • the light absorbency at 400mn was measured by spectrophotometer and the amount of generated melanin was indicated as the light absorbency per unit number of cells (10 6 cells). Then, the inhibition ratio (%) was obtained by calculating the amount of generated melanin relative to the control group, and the results are described in Table 1.
  • composition for skin whitening was prepared by adding
  • machilin-A to the cosmetics such as ointment for external use, cream, softening lotion,
  • Machilin-A obtained according to the extraction example was added as an effective component, and then ointments for external use were manufactured with the components and contents as described in Table 2.
  • Ointments for external use were manufactured with the components and contents as described in Table 2 without adding machilin-A.
  • Creams were manufactured with the components and contents as described in Table 3 without adding machilin-A.
  • Softening lotions were manufactured with the components and contents as described in Table 4 without adding machilin-A.
  • Embodiment 5 Machilin-A obtained according to the extraction example was added as an effective component, and then packs were manufactured with the components and contents as described in Table 6.
  • Nutritious lotions were manufactured with the components and contents as described in Table 7 without adding machilin-A.
  • the process for testing the pigmentation inhibitory effect by the ointment for external use, cream, softening lotion, essence, pack, and nutritious lotion manufactured as described above is as follows. First, an aluminum foil having two rows of six holes of 7mm diameter was adhered to each forearm of twenty healthy men and women, and 60 mJ/cm 2 of light was irradiated at 10cm distance from the arm by ORIEL solar simulator 1000W. Before the irradiation, the portion to be irradiated was washed with 70% aqueous ethanol solution.
  • the cosmetic compositions containing machilin-A according to the embodiments 1 to 6 and the cosmetic compositions not containing machilin-A according to the comparative examples 1 to 6 were applied to the same row respectively in pairs twice a day.
  • the packs of the embodiment 5 and the comparative examples 5 were removed 15 minutes after the application.
  • the pigmentation degree is determined with an naked eye. Then, the degrees of restraining pigmentation of the cosmetic compositions according to the embodiments were compared with those of the comparative examples respectively, and the result was evaluated into two stages, i.e., effective and no-difference, and was depicted in the following Table 8 along with the result of side effect occurrence.
  • the composition for skin whitening containing machilin-A according to the present invention shows a superior effect to inhibit pigmentation on skin by restraining melanin from being generated, so it is very effective to eliminate chloasma and freckles.
  • the composition of the present invention may be used safely since it shows no side effects on skin.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)

Abstract

Disclosed is composition for skin whitening containing machilin-A as an effective component. Machilin-A shows no side effect on skin, and has a superior effect to inhibit pigmentation on skin by restraining melanin from being generated. Thus, the composition containing the same is effectively used for skin whitening.

Description

COMPOSITION FOR SKIN WHITENING CONTAINING MACHILIN-A
TECHNICAL FIELD ' The present invention relates to composition for skin whitening, and more particularly to composition for skin whitening that has excellent stability with giving no side effects on skin, and have a superior effect to inhibit pigmentation on skin by restraining melanin from being generated.
BACKGROUND ART Most people want to have white and fine skin. The color of human skin is determined by the density and the distribution of melanin inside skin and affected by the environmental or physiological factors such as ultraviolet rays of the sun, fatigue, or stress as well as the genetic factor. Melanin is made through the following steps: first, enzyme tyrosinase affects on a kind of amino acid, tyrosine, to change the same into DOPA or dopaquinone and then the same goes through non-enzymatic oxidation reaction. However, the mechanism that derives melanin synthesis, which is a step before tyrosinase affects, is not clarified in detail though the process through which melanin is made is disclosed.
When the melanin synthesis is excessively performed inside skin, the tone of skin darkens, and chloasma and freckles can be generated. Accordingly, when the melanin synthesis inside skin is inhibited, the skin whitening is possible, plus hyperpigmentation such as chloasma, freckles, etc. due to ultraviolet rays or hormonic and genetic factors can be improved. Conventionally, the skin whitening is tried by mixing material having inhibition function against tyrosinase such as hydroquinone, ascorbic acid, kojic acid, or glutathione with cosmetic such as essence or ointment for external use. However, although hydroqumone shows a prescribed effect of whitening, the mixture amount of the same should be restricted to the minimum since the same seriously irritates skin. In case of ascorbic acid, since the same is easy to be oxidized, cosmetic mixed with the same has problems of discoloration and change of scent. In addition, in case of kojic acid, the same is restricted to be used since the same is unstable. Further, thiol compound such as glutathione or cysteine has a peculiar bad smell and low absorptiveness to skin.
DISCLOSURE OF THE INVENTION
Accordingly, the present invention is designed to solve the problems of the prior art, and an object of the present invention is to provide composition for skin whitening that has excellent stability with giving no side effects on skin, and has a superior effect to inhibit pigmentation on skin by restraining melanin from being generated.
In order to accomplish the object, the present invention provides composition for skin whitening containing machilin-A expressed by the following Chemical Formula 1 as an effective component.
Chemical Formula 1
Figure imgf000004_0001
At this time, the content of the machilin-A is preferably 0.000001 to 10 weight% on the basis of total weight of the composition, more particularly 0.0001 to 10 weight% on the basis of total weight of the composition.
Preferably, the machilin-A is extracted from Areca catechu by means of at least one solvent selected from the group consisting of low alcohol having 1 to 4 carbon atoms, ethyl acetate, acetone, ether, benzene, chloroform, hexane, cyclohexane and petroleum ether. In addition, the composition for skin whitening may have one form selected from the group consisting of skin, lotion, cream, foundation, essence, gel, pack, foam cleansing, soup and ointment for external use.
DESCRIPTION OF THE PREFERRED EMBODIMENTS Hereinafter, composition for skin whitening according to the present invention will be described in detail.
The composition for skin whitening according to the present invention contains machilin-A (machilin-A; CAS No. 110269-50-6 5,5'[(2R,3S)-dimethyl-l,4- butanediyl]bis-l, 3-bezodioxole), which is expressed by the following chemical formula 1, as an effective component for skin whitening. Chemical Formula 1
Figure imgf000005_0001
It was reported that machilin-A is a machilin derivative different from nor- dihydroguaiaretic acid, and may be used as an antioxidant (Chem. Pharm. (1990), 21(4), 270-3).
Though machilin-A is known as an antioxidant, the inventors have found that machilin-A show very strong inhibitory effect on formation of melanin and show excellent skin whitening effect as a result from the experiment on B16 mouse melanoma cell which can screen even the material which restrains induction of melanin synthesis itself. Therefore, if machilin-A is added and mixed into the composition for skin whitening such as skin lotion, cream, foundation, essence, gel, pack, foam cleansing, soap and ointment for external use according to the present invention, the high-potency of skin whitening without any special side effect can be obtained.
Machilin-A, an effective whitening component of the composition for skin whitening according to the present invention, is an organic compound having 20 carbon atoms, and may be obtained from essential oil of a microbe, a plant or an animal. In particular, machilin-A may be extracted from peel or root of Area catechu, but not limitedly. An extraction method of machilin-A from Areca catechu will be explained below as an example.
At first, after purchasing and pulverizing peel or root of Areca catechu which is sold in the market as a crude material, the pulverized peel or root is heat-extracted at 50 to 100°C for 1 to 5 hours in an extractor having a spill cooler by means of a coolant such as low alcohol having 1 to 4 carbon atoms, ethyl acetate, acetone, ether, benzene, chloroform, hexane, cyclohexane or petroleum ether. The extract is filtered by a filter cloth, and the residue is then extracted once more in the same way and added to the extract liquid, and then vacuum-concentrated, and freeze-dried or spray-dried to obtain a dried extract. The dried extract is suspended in water, adding ethyl acetate of the same amount thereto, thereby obtaining ethyl acetate fraction by liquid-liquid extraction.
The fraction is then purified by HPLC (High Performance Liquid Chromatography) or column chromatography filled with silica gel or activated alumina.
Machilin-A obtained by the above mentioned method can be added into various skin whitening compositions such as ointment for external use or cosmetic. The content of machilin-A contained in the skin whitening composition of the present invention is preferably 0.000001 to 10 weight% based on the total weight of the composition in consideration of whitening effect and economic efficiency, more preferably 0.0001 to 10 weight%.
The detailed description of the present invention referring to the embodiments is provided hereinafter. However, the embodiments according to the present invention can be modified in various ways and should not be understood that the present invention is restricted to the embodiments described below. The embodiments of the present invention are provided for illustration purpose only to a person having ordinary skill in the art.
Embodiments Extraction Examples of Machilin-A
Extraction Example 1
After purchasing a peel of Areca catechu in the market and then pulverizing it, lOOg of the pulverized peel was put into 500ml of 100% ethyl acetate, and then boiled in a spill extractor having a cooling condenser for 3 hours for the purpose of extraction. Subsequently, the extract was filtered by a 300-mesh filter cloth, and the residue was extracted once more in the same way. The extract liquids were mixed and filtered by Whatman No.2 filter paper at a room temperature to remove insoluble materials, and then vacuum-concentrated at 60°C in a distiller having a cooling condenser and suspended in 300ml of a purified water. 300ml of ethyl acetate was added thereto, and well stirred to obtain an ethyl acetate solution. Subsequently, 450ml of fraction containing an effective component was obtained from the ethyl acetate by using the silica gel column chromatography. It was again purified by HPLC to obtain 200mg of machilin-A. The structure of the machilin-A was validated using mass-spectroscopy and NMR spectroscopy.
Extraction Example 2
105mg of machilin-A was obtained using substantially the same way as the extraction example 1, except that 500ml of 100% ethanol was used instead of 500ml of 100% ethyl acetate.
Extraction Example 3
208mg of machilin-A was obtained using substantially the same way as the extraction example 1, except that 500ml of 100% chloroform was used instead of 500ml of 100% ethyl acetate.
Extraction Example 4
A peel of Areca catechu was purchased in the market and then pulverized, and then lOOg of the pulverized peel was put into 500ml of 100% capric/caprilic triester and then boiled in a spill extractor having a cooling condenser for 3 hours for the purpose of extraction. Subsequently, the extract was filtered by a 300-mesh filter cloth, and then filtered by Whatman No.2 filter paper at a room temperature to remove insoluble materials, and then purified by HPLC to obtain 150mg of machilin-A.
Extraction Example 5
208mg of machilin-A was obtained using substantially the same way as the extraction example 1, except that a pulverized root was put instead of the pulverized peel of Areca catechu and 500ml of n-hexane was used instead of 500ml of 100% ethyl acetate.
Extraction Example 6
208mg of machilin-A was obtained using substantially the same way as the extraction example 1, except that 500ml of n-hexane was used instead of 500ml of 100% ethyl acetate.
Experimental Examples 1 to 3 The whitening effect in a cellular level was tested by adding aqueous solutions of hydroqumone and machilin-A obtained according to the above extraction examples to a culture medium of B-16 mouse melanoma cell (Lotan R., Lotan D. Cancer Res. 40:3345-3350, 1980). The final concentrations of machilin-A were prepared to be 1 μg/ml, 5μg/ml and 20 μg/ml respectively (Experimental Examples 1 to 3) and the final concentration of hydroquinone was prepared to be 1 μg/ml, and each was added to the culture medium of B-16 mouse melanoma cell, and then cultured for 3 days. Next, the cultured cells were treated with trypsin, and separated from the culture plate, and then centrifuged to extract melanin. lml of sodium hydroxide solution (IN of concentration) was added to each of above obtained extracts and the mixtures were boiled for 10 minutes for melanin to melt.
Then, the light absorbency at 400mn was measured by spectrophotometer and the amount of generated melanin was indicated as the light absorbency per unit number of cells (106 cells). Then, the inhibition ratio (%) was obtained by calculating the amount of generated melanin relative to the control group, and the results are described in Table 1.
Table 1
Figure imgf000010_0001
* number of replication = 3
Referring to Table 1, it is found that machilin-A has a very high-potency of
restraining the generation of melanin of the cultured mouse melanoma cells, when
compared with that of the control group (see Experimental Examples 1 to 3), and it may also be understood that its effect is not behind hydroquinone, which is a well-known
whitening material. In addition, hydroquinone cannot be applied at a concentration of
1 μg/ml or above due to its toxicity though it shows very strong potency of restraining
the generation of melanin at a low concentration. However, machilin-A is not showing
cell toxicity even at a high concentration of 20 μg/ml or above, so it may give excellent
effects in restraining the generation of melanin rather then hydroquinone.
Hereinafter, the composition for skin whitening was prepared by adding
machilin-A to the cosmetics such as ointment for external use, cream, softening lotion,
essence, pack, and nutritious lotion, and then the effect of inhibiting pigmentation was
tested by applying it to the testees. Embodiment 1
Machilin-A obtained according to the extraction example was added as an effective component, and then ointments for external use were manufactured with the components and contents as described in Table 2.
Comparative Example 1
Ointments for external use were manufactured with the components and contents as described in Table 2 without adding machilin-A.
Table 2
Figure imgf000011_0001
Embodiment 2
Machilin-A obtained according to the extraction example was added as an effective component, and then creams were manufactured with the components and contents as described in Table 3.
Comparative Example 2
Creams were manufactured with the components and contents as described in Table 3 without adding machilin-A.
Table 3
Figure imgf000012_0001
Embodiment 3
Machilin-A obtained according to the extraction example was added as an effective component, and then softening lotions were manufactured with the components and contents as described in Table 4.
Comparative Example 3
Softening lotions were manufactured with the components and contents as described in Table 4 without adding machilin-A.
Table 4
Figure imgf000012_0002
Figure imgf000013_0001
Embodiment 4
Machilin-A obtained according to the extraction example was added as an effective component, and then essences were manufactured with the components and contents as described in Table 5.
Comparative Example 4
Essences were manufactured with the components and contents as described in Table 5 without adding machilin-A.
Table 5
Figure imgf000013_0002
Embodiment 5 Machilin-A obtained according to the extraction example was added as an effective component, and then packs were manufactured with the components and contents as described in Table 6.
Comparative Example 5
Packs were manufactured with the components and contents as described in Table 6 without adding machilin-A.
Table 6
Figure imgf000014_0001
Embodiment 6
Machilin-A obtained according to the extraction example was added as an effective component, and then nutritious lotions were manufactured with the components and contents as described in Table 7. Comparative Example 6
Nutritious lotions were manufactured with the components and contents as described in Table 7 without adding machilin-A.
Table 7
Figure imgf000015_0001
The process for testing the pigmentation inhibitory effect by the ointment for external use, cream, softening lotion, essence, pack, and nutritious lotion manufactured as described above is as follows. First, an aluminum foil having two rows of six holes of 7mm diameter was adhered to each forearm of twenty healthy men and women, and 60 mJ/cm2 of light was irradiated at 10cm distance from the arm by ORIEL solar simulator 1000W. Before the irradiation, the portion to be irradiated was washed with 70% aqueous ethanol solution. From 3 days before the irradiation to 3 weeks after the irradiation, the cosmetic compositions containing machilin-A according to the embodiments 1 to 6 and the cosmetic compositions not containing machilin-A according to the comparative examples 1 to 6 were applied to the same row respectively in pairs twice a day. The packs of the embodiment 5 and the comparative examples 5 were removed 15 minutes after the application.
After applying the cosmetic compositions according to each embodiment and comparative example to the testees as described above, the pigmentation degree is determined with an naked eye. Then, the degrees of restraining pigmentation of the cosmetic compositions according to the embodiments were compared with those of the comparative examples respectively, and the result was evaluated into two stages, i.e., effective and no-difference, and was depicted in the following Table 8 along with the result of side effect occurrence.
Table 8
Figure imgf000016_0001
As shown in Table 8, at least 13 persons of 20 testees to whom the cosmetic compositions containing machilin-A according to ihe embodiments 1 to 6 show superior skin whitening effect without no side effect.
INDUSTRIAL APPLICABILITY As described above, the composition for skin whitening containing machilin-A according to the present invention shows a superior effect to inhibit pigmentation on skin by restraining melanin from being generated, so it is very effective to eliminate chloasma and freckles. In addition, the composition of the present invention may be used safely since it shows no side effects on skin.
The present invention has been described in detail. However, it should be understood that the detailed description and specific examples, while indicating preferred embodiments of the invention, are given by way of illustration only, since various changes and modifications within the spirit and scope of the invention will become apparent to those skilled in the art from this detailed description.

Claims

WHAT IS CLAIMED IS:
1. Composition for skin whitening containing machilin-A expressed by the following Chemical Formula 1 as an effective component.
Chemical Formula 1
Figure imgf000018_0001
2. Composition for skin whitening according to claim 1, wherein the content of the machilin-A is 0.000001 to 10 weight% on the basis of total weight of the composition.
3. Composition for skin whitening according to claim 2, wherein the content of the machilin-A is 0.0001 to 10 weight% on the basis of total weight of the composition.
4. Composition for skin whitening according to claim 1, wherein the machilin-A is extracted from Areca catechu by means of at least one solvent selected from the group consisting of low alcohol having 1 to 4 carbon atoms, ethyl acetate, acetone, ether, benzene, chloroform, hexane, cyclohexane and petroleum ether.
5. Composition for skin whitening according to claim 1, wherein the composition for skin whitening has one form selected from the group consisting of skin, lotion, cream, foundation, essence, gel, pack, foam cleansing, soup and ointment for external use.
PCT/KR2003/000738 2003-04-12 2003-04-12 Composition for skin whitening containing machilin-a WO2004089328A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/KR2003/000738 WO2004089328A1 (en) 2003-04-12 2003-04-12 Composition for skin whitening containing machilin-a
AU2003225373A AU2003225373A1 (en) 2003-04-12 2003-04-12 Composition for skin whitening containing machilin-a

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/KR2003/000738 WO2004089328A1 (en) 2003-04-12 2003-04-12 Composition for skin whitening containing machilin-a

Publications (1)

Publication Number Publication Date
WO2004089328A1 true WO2004089328A1 (en) 2004-10-21

Family

ID=33157238

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2003/000738 WO2004089328A1 (en) 2003-04-12 2003-04-12 Composition for skin whitening containing machilin-a

Country Status (2)

Country Link
AU (1) AU2003225373A1 (en)
WO (1) WO2004089328A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100770124B1 (en) * 2001-11-08 2007-10-24 주식회사 엘지생활건강 Composition for skin whitening containing machilin-A

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06227960A (en) * 1993-02-01 1994-08-16 Yakult Honsha Co Ltd Melanin formation inhibitor and skin cosmetic
KR20020090544A (en) * 2001-05-28 2002-12-05 주식회사 바이오랜드 Whitening and wrinkle improvement cosmetics composition containing areca catechu extract and arbutin

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06227960A (en) * 1993-02-01 1994-08-16 Yakult Honsha Co Ltd Melanin formation inhibitor and skin cosmetic
KR20020090544A (en) * 2001-05-28 2002-12-05 주식회사 바이오랜드 Whitening and wrinkle improvement cosmetics composition containing areca catechu extract and arbutin

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
LEE, K.K. ET AL.: "Areca catechu L.Extract II. Effects on Inflammation and Melanogenesis", JOURNAL OF THE SOCIETY OF COSMETIC CHEMISTS, vol. 49, no. 6, 1998, pages 351 - 359 *
LEE, K.K. ET AL.: "The Effects of Areca catechu L.Extract on Anti-Inflammation and Anti-Melanogenesis", INTERNATIONAL JOURNAL OF COSMETIC SCIENCE, vol. 21, no. 4, 1999, pages 275 - 284 *
LI, G. ET AL: "Melanin Biosynthesis Inhibitors from the Bark of Machilus thunbergii", BIOLOGICAL & PHARMACEUTICAL BULLETIN, vol. 26, no. 7, 1 July 2003 (2003-07-01), pages 1039 - 1041, XP002904866, DOI: doi:10.1248/bpb.26.1039 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100770124B1 (en) * 2001-11-08 2007-10-24 주식회사 엘지생활건강 Composition for skin whitening containing machilin-A

Also Published As

Publication number Publication date
AU2003225373A1 (en) 2004-11-01

Similar Documents

Publication Publication Date Title
TWI293888B (en) Cosmetic composition
KR100777554B1 (en) Composition for skin whitening containing Sitosterol
KR100454736B1 (en) Composition for skin whitening containing veratramine
KR100190992B1 (en) A skin whitening composition containing extracts of asparagus cochinchinensis and tyrosinase inhibitor
KR100190993B1 (en) Water soluble fraction extracts of asparagus cochinchinensis having improved skin whitening defects by removing darkening components and a composition for improving freckles and skin whitening containing thereof
KR20090131767A (en) Cosmetics composition for skin whitening
KR20050092313A (en) Skin whitening cosmetic containing a herb extract with inhibitory activity of melanin formation
KR100789632B1 (en) Cosmetic for skin whitening containing a herb extract with inhibitory activity of melanin formation
KR100757130B1 (en) Cosmetic for skin whitening containing verazine and epi-verazine with inhibitory activity of melanin formation
KR100453217B1 (en) Skin whitener
KR100789634B1 (en) Cosmetic for skin whitening containing a herb extract with inhibitory activity of melanin formation
JP2000007546A (en) Pigmentation preventing agent and skin cosmetic and skin lotion produced by using the agent
WO2000071092A1 (en) Skin whitener
KR100509848B1 (en) Composition for skin whitening
WO2004089328A1 (en) Composition for skin whitening containing machilin-a
KR100431271B1 (en) Composition for skin whitening containing Arecoline
KR20050092314A (en) Skin whitening cosmetic containing a herb extract with inhibitory activity of melanin formation
KR100770124B1 (en) Composition for skin whitening containing machilin-A
KR20040059005A (en) Skin Whitening Cosmetic containing a herb extract with inhibitory activity of melanin formation
KR100777589B1 (en) Composition for skin whitening containing Physalindicanol-A
KR100724168B1 (en) Cosmetic for skin whitening containing a herb extract with inhibitory activity of melanin formation
CN100352825C (en) Extractive form active ingredient of bitter bamboo, prepartion method and application
KR20040059004A (en) Skin Whitening Cosmetic containing a herb extract with inhibitory activity of melanin formation
KR20050037103A (en) Cosmetic composition for whitening of the skin
KR20040059007A (en) Skin Whitening Cosmetic containing a herb extract with inhibitory activity of melanin formation

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP